Wegner, J.; Saloga, J.; Grabbe, S. et al.
IgE-specific immunoadsorption for treatment of severe atopic dermatitisEXPERIMENTAL DERMATOLOGY. Bd. 26. H. 3. 2017 S. E31-E32
Woerns, Marcus-Alexander; Galle, Peter R.
Immune oncology in hepatocellular carcinoma-hype and hopeLANCET. Bd. 389. H. 10088. 2017 S. 2448-2449
Wegner, Joanna; Weinmann-Menke, Julia; von Stebut, Esther
Immunoadsorption for treatment of severe atopic dermatitisATHEROSCLEROSIS SUPPLEMENTS. Bd. 30. 2017 S. 264-270
Heinrich, B.; Klein, J.; Delic, M. et al.
Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytesONCOTARGETS AND THERAPY. Bd. 10. 2017 S. 2389-2401
Stintzing, S.; Miller-Phillips, L.; Modest, D. P. et al.
Impact of BRAF and RAS mutations on first-line efficacy of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab: analysis of the FIRE-3 (AIO KRK-0306) studyEUROPEAN JOURNAL OF CANCER. Bd. 79. 2017 S. 50-60
Herzer, K.; Gerken, G.; Kroy, D. et al.
IMPACT OF DIRECT-ACTING ANTIVIRAL THERAPY ON THE NEED FOR LIVER TRANSPLANTATION RELATED TO HEPATITIS C IN GERMANYTRANSPLANT INTERNATIONAL. Bd. 30. 2017 S. 18-18
Herzer, Kerstin; Gerken, Guido; Kroy, Daniela et al.
Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in GermanyHEPATOLOGY. Bd. 66. 2017 S. 877A-877A
Labenz, Christian; Prenosil, Vera; Koch, Sandra et al.
Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with SorafenibDIGESTIVE DISEASES. Bd. 36. H. 1. 2017 S. 78-88
Sprinzl, M. F.; Koch, S.; Seib, M. L. et al.
Improved prediction of survival by a risk factor-integrated inflammatory score in Sorafenib treated hepatocellular carcinomaJOURNAL OF HEPATOLOGY. Bd. 66. H. 1. 2017 S. S452-S453
Metzger, Jan-Christopher; Wollschlaeger, Daniel; Miederer, Matthias et al.
Inclusion of PET-CT into planning of primary or neoadjuvant chemoradiotherapy of esophageal cancer improves prognosisSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 193. H. 10. 2017 S. 791-799